Literature DB >> 34007332

Histone demethylase KDM2A: Biological functions and clinical values (Review).

Lisheng Liu1,2, Jiangnan Liu3, Qinghai Lin2.   

Abstract

Histone lysine demethylation modification is a critical epigenetic modification. Lysine demethylase 2A (KDM2A), a Jumonji C domain-containing demethylase, demethylates the dimethylated H3 lysine 36 (H3K36) residue and exerts little or no activity on monomethylated and trimethylated H3K36 residues. KDM2A expression is regulated by several factors, such as microRNAs, and the phosphorylation of KDM2A also plays a vital role in its function. KDM2A mainly recognizes the unmethylated region of CpG islands and subsequently demethylates histone H3K36 residues. In addition, KDM2A recognizes and binds to phosphorylated proteins, and promotes their ubiquitination and degradation. KDM2A plays an important role in chromosome remodeling and gene transcription, and is involved in cell proliferation and differentiation, cell metabolism, heterochromosomal homeostasis and gene stability. Notably, KDM2A is crucial for tumorigenesis and progression. In the present review, the documented biological functions of KDM2A in physiological and pathological processes are comprehensively summarized.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  cell differentiation; demethylation; epigenetic; tumorigenesis

Year:  2021        PMID: 34007332      PMCID: PMC8120640          DOI: 10.3892/etm.2021.10155

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  77 in total

1.  Histone demethylation by a family of JmjC domain-containing proteins.

Authors:  Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang
Journal:  Nature       Date:  2005-12-18       Impact factor: 49.962

2.  HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.

Authors:  Rongying Ou; Linyu Zhu; Liang Zhao; Wenfeng Li; Fengxing Tao; Yiyi Lu; Qin He; Jianrong Li; Yi Ren; Yunsheng Xu
Journal:  J Cell Physiol       Date:  2018-08-21       Impact factor: 6.384

3.  The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner.

Authors:  Tao Wang; Keshi Chen; Xiaoming Zeng; Jianguo Yang; Yun Wu; Xi Shi; Baoming Qin; Lingwen Zeng; Miguel Angel Esteban; Guangjin Pan; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2011-11-17       Impact factor: 24.633

4.  Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.

Authors:  Shilpa S Dhar; Hunain Alam; Na Li; Klaus W Wagner; Jimyung Chung; Yeo Won Ahn; Min Gyu Lee
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

5.  The histone demethylase Fbxl11/Kdm2a plays an essential role in embryonic development by repressing cell-cycle regulators.

Authors:  Eri Kawakami; Akinori Tokunaga; Manabu Ozawa; Reiko Sakamoto; Nobuaki Yoshida
Journal:  Mech Dev       Date:  2014-10-30       Impact factor: 1.882

6.  Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

Authors:  Yujiang Shi; Fei Lan; Caitlin Matson; Peter Mulligan; Johnathan R Whetstine; Philip A Cole; Robert A Casero; Yang Shi
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

7.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23

8.  LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.

Authors:  Wanqiang Sheng; Martin W LaFleur; Thao H Nguyen; Sujun Chen; Ankur Chakravarthy; Jake Ryan Conway; Ying Li; Hao Chen; Henry Yang; Pang-Hung Hsu; Eliezer M Van Allen; Gordon J Freeman; Daniel D De Carvalho; Housheng Hansen He; Arlene H Sharpe; Yang Shi
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

Review 9.  Recent Progress in Histone Demethylase Inhibitors.

Authors:  Tom E McAllister; Katherine S England; Richard J Hopkinson; Paul E Brennan; Akane Kawamura; Christopher J Schofield
Journal:  J Med Chem       Date:  2016-02-02       Impact factor: 7.446

Review 10.  Writing, erasing and reading histone lysine methylations.

Authors:  Kwangbeom Hyun; Jongcheol Jeon; Kihyun Park; Jaehoon Kim
Journal:  Exp Mol Med       Date:  2017-04-28       Impact factor: 8.718

View more
  4 in total

1.  NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.

Authors:  Jiatian Lin; Xiangling Chen; Hongjian Yu; Shasha Min; Yequn Chen; Zesong Li; Xina Xie
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

2.  CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells.

Authors:  Ayako Kawabata; Tomoatsu Hayashi; Yoko Akasu-Nagayoshi; Ai Yamada; Naomi Shimizu; Naoko Yokota; Ryuichiro Nakato; Katsuhiko Shirahige; Aikou Okamoto; Tetsu Akiyama
Journal:  Curr Issues Mol Biol       Date:  2022-04-07       Impact factor: 2.976

3.  Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.

Authors:  Bing Lu; Jiatian Wei; Houhong Zhou; Jie Chen; Yuqing Li; Liefu Ye; Wei Zhao; Song Wu
Journal:  Cell Death Dis       Date:  2022-06-13       Impact factor: 9.685

Review 4.  Lactylation: a Passing Fad or the Future of Posttranslational Modification.

Authors:  Qi Xin; Hai Wang; Qinglin Li; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Inflammation       Date:  2022-02-27       Impact factor: 4.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.